Avalon Trust »

Vaneck Vectors Pharmaceutical etf shares owned by Avalon Trust

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Avalon Trust from 13F filings

Historical chart of Avalon Trust investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Avalon Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Avalon Trust

Quarter filed Position value Share count Share price at filing
2023-12-31 $23M 285k 81.37
2023-09-30 $23M 288k 79.86
2023-06-30 $23M 286k 78.77
2023-03-31 $22M 286k 77.63

More positions owned by Avalon Trust

Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Broadcom (AVGO)
Visa Com Cl A (V)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Lowe's Companies (LOW)
Ishares Tr Ishares Semicdtr (SOXX)
Progressive Corporation (PGR)
Mondelez Intl Cl A (MDLZ)
NVR (NVR)
CVS Caremark Corporation (CVS)
Vaneck Etf Trust Pharmaceutcl Etf (PPH)
PNC Financial Services (PNC)

View all positions for Avalon Trust

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Bank of America Corporation
Healthcare Of Ontario Pension Plan Trust Fund
Avalon Trust
Jpmorgan Chase & Co
Miller Investment Management
Prime Capital Investment Advisors
Bnp Paribas Arbitrage, Snc
Independent Advisor Alliance
Phoenix Holdings
Citadel Advisors
Avestar Capital
Gladstone Institutional Advisory
Hrt Financial
Twelve Points Wealth Management

View all funds holding Vaneck Vectors Pharmaceutical etf